Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Riediger, P. Berberat, P. Sauer, D. Gotthardt, K. Weiss, A. Mehrabi, U. Merle, W. Stremmel, J. Encke (2007)
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22 Suppl 8
W. Yeo, P. Chan, W. Ho, B. Zee, K. Lam, K. Lei, A. Chan, T. Mok, Jam Lee, T. Leung, S. Zhong, P. Johnson (2004)
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 5
Yutaka Tsutsumi, Junzo Tanaka, T. Kawamura, T. Miura, H. Kanamori, S. Obara, M. Asaka, M. Imamura, N. Masauzi (2003)
Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphomaAnnals of Hematology, 83
Y. Tsutsumi, H. Kanamori, A. Mori, J. Tanaka, M. Asaka, M. Imamura, N. Masauzi (2005)
Reactivation of hepatitis B virus with rituximabExpert Opinion on Drug Safety, 4
Joanna Law, Jaber Ali, P. Harrigan, C. Sherlock, K. Savage, E. Yoshida (2006)
Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patientAmerican Journal of Hematology, 81
Toshiki Sera, Y. Hiasa, K. Michitaka, I. Konishi, Kana Matsuura, Yoshio Tokumoto, B. Matsuura, T. Kajiwara, T. Masumoto, N. Horiike, M. Onji (2006)
Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab.Internal medicine, 45 11
Yi-Fu He, Yu-hong Li, Fenghua Wang, Wen-Qi Jiang, Rui-Hua Xu, Xiao-fei Sun, Z. Xia, Huiqiang Huang, T. Lin, Li Zhang, S. Bao, You-jian He, Z. Guan (2008)
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphomaAnnals of Hematology, 87
Ming-Huang Chen, L. Hsiao, T. Chiou, Jin-Hwang Liu, J. Gau, H. Teng, Wei-shu Wang, T. Chao, C. Yen, Po-min Chen (2008)
High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphomaAnnals of Hematology, 87
B. Coiffier (2006)
Hepatitis B Virus Reactivation in Patients Receiving Chemotherapy for Cancer Treatment: Role of Lamivudine ProphylaxisCancer Investigation, 24
Ching‐lung Lai, R. Chien, N. Leung, Ting Chang, R. Guan, D. Tai, K. Ng, P. Wu, J. Dent, J. Barber, S. Stephenson, D. Gray (1998)
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.The New England journal of medicine, 339 2
Chiun Hsu, C. Hsiung, I. Su, W. Hwang, Ming-Chung Wang, Sheng‐Fung Lin, T. Lin, H. Hsiao, Ji‐Hsiung Young, M. Chang, Y. Liao, C. Li, Hung-Bo Wu, H. Tien, T. Chao, T. Liu, A. Cheng, Pei‐Jer Chen (2008)
A revisit of prophylactic lamivudine for chemotherapy‐associated hepatitis B reactivation in non‐Hodgkin's lymphoma: A randomized trialHepatology, 47
W. Su, C. Wen, C. Hsiung, I. Su, A. Cheng, M. Chang, C. Tsao, Woei-Yao Kao, W. Uen, C. Hsu, Chih-Hung Hsu, Yen-Shen Lu, H. Tien, T. Chao, Li‐Tzong Chen, J. Whang‐Peng, Pei‐Jer Chen (2005)
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients.World journal of gastroenterology, 11 34
S. Takai, H. Tsurumi, K. Ando, S. Kasahara, M. Sawada, T. Yamada, T. Hara, K. Fukuno, Takeshi Takahashi, M. Oyama, Hiroo Onishi, E. Tomita, T. Takami, M. Imawari, H. Moriwaki (2005)
Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapyEuropean Journal of Haematology, 74
M. Kuniyoshi, M. Nakamuta, H. Sakai, M. Enjoji, N. Kinukawa, K. Kotoh, M. Fukutomi, M. Yokota, H. Nishi, H. Iwamoto, N. Uike, J. Nishimura, S. Inaba, Y. Maeda, H. Nawata, K. Muta (2001)
Prevalence of hepatitis B or C virus infections in patients with non‐Hodgkin's lymphomaJournal of Gastroenterology and Hepatology, 16
C. Targhetta, M. Cabras, A. Mamusa, G. Mascia, E. Angelucci (2008)
Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapyHaematologica, 93
Gian Zuccotti, C. Cucchi, Valentina Gracchi, Enza D'Auria, E. Riva, A. Tagger (2002)
A 1-Year Trial of Lamivudine for Chronic Hepatitis B in ChildrenJournal of International Medical Research, 30
J. Law, J. Ho, P. Hoskins, S. Erb, U. Steinbrecher, E. Yoshida (2005)
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendationsLeukemia & Lymphoma, 46
J. Kim, Y. Bang, B. Park, Taiwoo Yoo, C. Kim, Tae-You Kim, D. Heo, Hyo‐suk Lee, N. Kim (2002)
Hepatitis B Virus Infection and B‐Cell Non‐Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case‐control StudyJapanese Journal of Cancer Research : Gann, 93
N. Simpson, Peter Simpson, A. Ahmed, M. Nguyen, G. Garcia, E. Keeffe, Aijaz Ahmed (2003)
Prophylaxis Against Chemotherapy-Induced Reactivation of Hepatitis B Virus Infection With LamivudineJournal of Clinical Gastroenterology, 37
F. Marcucci, A. Mele, E. Spada, Â. Cândido, E. Bianco, A. Pulsoni, P. Chionne, E. Madonna, R. Cotichini, A. Barbui, A. Renzo, F. Dore, E. Iannitto, V. Liso, B. Martino, M. Montanaro, L. Pagano, P. Musto, M. Rapicetta (2006)
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.Haematologica, 91 4
Y. Kawamura, K. Ikeda, Y. Arase, Hiromi Yatsuji, H. Sezaki, T. Hosaka, N. Akuta, M. Kobayashi, F. Suzuki, Yoshiyuki Suzuki, H. Kumada (2007)
Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.The American journal of medicine, 120 12
Y. Tsutsumi, T. Kawamura, Shin Saitoh, M. Yamada, S. Obara, T. Miura, H. Kanamori, J. Tanaka, M. Asaka, M. Imamura, N. Masauzi (2004)
Hepatitis B Virus Reactivation in a Case of Non-Hodgkin's Lymphoma Treated with Chemotherapy and Rituximab: Necessity of Prophylaxis for Hepatitis B Virus Reactivation in Rituximab TherapyLeukemia & Lymphoma, 45
J. Dienstag, E. Schiff, T. Wright, R. Perrillo, H. Hann, Z. Goodman, L. Crowther, Lynn Condreay, M. Woessner, M. Rubin, N. Brown (1999)
Lamivudine as initial treatment for chronic hepatitis B in the United States.The New England journal of medicine, 341 17
G. Perceau, N. Diris, O. Estines, C. Derancourt, S. Lévy, P. Bernard (2006)
Late lethal hepatitis B virus reactivation after rituximab treatment of low‐grade cutaneous B‐cell lymphomaBritish Journal of Dermatology, 155
C. Sarrecchia, A. Cappelli, P. Aiello (2005)
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAbJournal of Infection and Chemotherapy, 11
S. Lim, G. Fei, R. Quek, L. Lim, L. Lee, S. Yap, S. Loong, M. Tao (2007)
The relationship of hepatitis B virus infection and non‐Hodgkin’s lymphoma and its impact on clinical characteristics and prognosisEuropean Journal of Haematology, 79
M. Picardi, F. Pane, C. Quintarelli, A. Renzo, A. Giudice, B. Divitiis, M. Persico, R. Ciancia, F. Salvatore, B. Rotoli (2003)
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.Haematologica, 88 11
Aijaz Ahmed, E. Keeffe (1999)
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infectionAmerican Journal of Gastroenterology, 94
C. Hui, W. Cheung, Hai‐ying Zhang, W. Au, Yui-hung Yueng, A. Leung, N. Leung, J. Luk, A. Lie, Y. Kwong, R. Liang, G. Lau (2006)
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.Gastroenterology, 131 1
Cancer – Wiley
Published: Jan 1, 2010
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.